Search for: "Generic Pharmaceutical Association"
Results 141 - 160
of 3,010
Sort by Relevance
|
Sort by Date
1 May 2023, 5:16 am
Quantum sensing is the only general category of quantum information science with U.S. export controls in place. [read post]
27 Apr 2023, 5:50 am
China’s Semiconductor Industry Association said export controls are “destroying the existing global semiconductor industry” and constitute an “act of tearing apart the global industrial system [that] will cause immeasurable harm. [read post]
24 Apr 2023, 6:10 am
An integral part of product life cycle management strategies for pharmaceutical corporations, product hops are reformulated versions of an often-lucrative brand-name drug, aimed at preserving market share after generics enter the marketplace. [read post]
21 Apr 2023, 6:00 am
FDA– Dobbs’s Collateral Consequences for Pharmaceutical Regulation. [read post]
19 Apr 2023, 12:45 am
Firms implementing a standard need to know the associated licensing cost early on in order to devise their pricing strategy, especially if the aggregate royalty could be a relevant share of their profit margin. [read post]
17 Apr 2023, 6:10 am
In 2019 generic mifepristone was approved. [read post]
17 Apr 2023, 6:10 am
In 2019 generic mifepristone was approved. [read post]
13 Apr 2023, 9:16 am
Patent Title US 11589674 B2 Side rail mounted organizer US 11591937 B2 Remotely mounted idler gear US 11591003 B2 Stowable steering column US 11591574 B2 Optical-quality surface that imparts spatial control of macrophage fusion US 11594682 B2 Semiconducting polymer blends for high temperature organic electronics US 11592201 B2 Space conditioning control and monitoring method and system US 11595430 B2 Security system using pseudonyms to anonymously identify entities and corresponding… [read post]
13 Apr 2023, 6:53 am
Top row from left to right, signing of joint statement of intent on accelerated patent grant with the Directorate General of the Industrial Property Registry of Panama and signing of memorandum of understanding with the Canadian Intellectual Property Office. [read post]
12 Apr 2023, 8:25 am
They generally charge an interesting fee schedule. [read post]
10 Apr 2023, 9:01 pm
In this column, we will explain some of its worst offenses—misunderstanding of and interference with the FDA’s process for evaluating the safety and efficacy of drugs; reliance on junk science to cobble together an unconvincing theory of standing for the plaintiffs and arbitrariness of the FDA’s approval; and the manipulation of science, law, and language to hew closely to the anti-abortion playbook.The Basics of the RulingThe plaintiffs who brought this case are described in the… [read post]
31 Mar 2023, 3:10 am
IMT argued that its sign would be associated with Mount Ararat or at least some mountain, but the GC considered that it would be seen just an abstract triangular geometric shape, at least by the majority of the relevant public. [read post]
30 Mar 2023, 7:10 am
Nevertheless, the majority of providers take on those risks to be reimbursed for the ASP, as this price is generally high. [read post]
30 Mar 2023, 7:10 am
Nevertheless, the majority of providers take on those risks to be reimbursed for the ASP, as this price is generally high. [read post]
29 Mar 2023, 2:50 am
Nonetheless, it of course opened the door for examiners and opponents to argue that an invention may not solely rely on post-published evidence for the effects asserted to be associated with the claimed subject-matter, absent a plausible showing that the teaching of the invention indeed solves the problem it purports to solve. [read post]
28 Mar 2023, 9:44 am
Reddy’s, Intas Pharmaceuticals, or BDR Pharmaceuticals), to supply patients purchasers through the Federal Supply Schedule, as well as the Medicare and Medicaid programs. [read post]
27 Mar 2023, 9:01 pm
We review a number of significant developments in Delaware corporate law, including the Court of Chancery’s clarification of directors’ oversight duties, and the Delaware General Assembly’s expansion of Section 102(b)(7) of the Delaware General Corporation Law to include exculpation of officers for personal liability arising from breaches of the duty of care. [read post]
24 Mar 2023, 7:48 am
2019: The FDA approved a generic version of mifepristone. 2021: The FDA removed in-person dispensing requirements. [read post]
23 Mar 2023, 10:37 am
Enrique Santamaría is a postdoctoral researcher at the Erasmus School of Law, Erasmus University Rotterdam and associate fellow at the Jean Monnet Centre of Excellence on Digital Governance. [read post]
23 Mar 2023, 5:32 am
It is known that ANVISA has discussed with the Brazilian Association of Generic and Biosimilar Drugs (called “PróGenéricos”) the possibility of legitimizing the practice even without any amendment. [read post]
